Sort
10,829 grants matching “car t”
RACE-CARS CCC 1/2
$1,688,573Christopher B. Granger · Duke University · UH3 · FY2023 · HL
RACE-CARS CCC 1/2
$1,688,573Christopher B. Granger · Duke University · UH3 · FY2022 · HL
HWWT
$1,684,520Lamont Byrd · International Brotherhood Of Teamsters · U45 · FY2012 · ES
Time Resolved Fluorescence Spectroscopy
$1,680,003Jay R Knutson · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
$1,679,994Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Immunotherapy of low grade lymphoid malignancies
$1,679,879Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
HWWT
$1,675,511Lamont Byrd · International Brotherhood Of Teamsters · U45 · FY2011 · ES
Multimodal AI modeling of T cell therapies to predict patient response and nominate advanced cell design strategies
$1,673,650Crystal Mackall · Stanford University · OT2 · FY2025 · OD
SBIR Phase II: Clinical scale and testing of the first virus-free precision gene edited cell therapy for veterinary oncology
$1,668,708Wesley A Wierson · Lifengine Animal Health Laboratories Incorporated · · FY2023 · TIP
HWWT
$1,665,628Lamont Byrd · International Brotherhood Of Teamsters · U45 · FY2010 · ES
Optimization of gene transfer and gene editing safety and efficacy focusing on the NHP model
$1,661,256Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Project 1
$1,657,050Carl H. June · University Of Pennsylvania · U54 · FY2019 · CA
REGIONAL ALLOGENEIC MESOTHELIN-TARGETED CAR (RAMCAR) T-CELL THERAPY FOR ESOPHAGEAL CANCER: CLINICAL TRIAL PREPARATION AND PHASE 1 CLINICAL TRIAL
$1,651,948Sloan-Kettering Institute For Cancer Research · · FY2021 · Defense Health Agency
Collaborative Research: Transferable, Hierarchical, Expressive, Optimal, Robust, Interpretable Networks
$1,650,000Soledad Villar · Johns Hopkins University · · FY2020 · MPS
GeoTech Geospatial Resource Center
$1,649,295Vincent A Dinoto · Kentucky Community & Technical College System · · FY2022 · EDU
Drug Metabolizing Enzymes In Humans And Animal Models
$1,649,113Joyce Goldstein · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Profiles of Sucsceptibility to Toxicant Stress
$1,648,823University Of North Carolina Chapel Hill · U19 · FY2005 · ES
Immune repertoire remodeling following B cell-targeted CAR T cells for induction of renal allograft tolerance in non-human primates
$1,648,086Ali Naji · University Of Pennsylvania · R01 · FY2025 · AI
UCLA SPORE in Prostate Cancer
$1,643,637Robert E Reiter · University Of California Los Angeles · P50 · FY2022 · CA
Functional Anatomy of Perceptual and Attentional Systems in the Primate Brain
$1,641,483Leslie G Ungerleider · National Institute Of Mental Health · ZIA · FY2018 · MH
RACE-CARS CCC 1/2
$1,638,818Christopher B. Granger · Duke University · UH3 · FY2024 · HL
FuSe: Co-designed Systems for In-sensor Processing with Sustainable Nanomaterials (COSMIC)
$1,634,180Tania Roy · Duke University · · FY2023 · ENG
PARTNER: AIPS: Expanding AI Innovation in Pervasive Systems at Arizona State University
$1,634,066Hassan G Zadeh · Arizona State University · · FY2024 · CSE
Profiles of Sucsceptibility to Toxicant Stress
$1,632,575University Of North Carolina Chapel Hill · U19 · FY2003 · ES
Development of new antibody-based cancer therapies
$1,629,751Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA